Design and trust in life science marketing are closely linked, especially in complex B2B buying environments. Well documented UX research from Nielsen Norman Group shows that B2B buyers rarely start by reading in depth.

In usability studies, users scan pages first, looking for structure and relevance before deciding whether to invest time in reading. Jakob Nielsen’s research also shows that users typically read only about 20 to 28 percent of the text on a web page during an average visit.

Eye tracking research described by Nielsen Norman Group reinforces this pattern. Headings, grouping, and visual cues guide attention early and shape whether content feels understandable and worth engaging with, before claims or arguments are evaluated.

This matters in B2B because buyers are often asked to assess complex offers with limited information early in the process. At the same time, they carry responsibility for technical fit, commercial impact, and internal credibility. To manage that uncertainty, they rely on cues that indicate whether information appears organised and intentional.

Design provides many of those cues. Through layout, hierarchy, typography, and flow, it signals how carefully information has been structured and how easily a buyer can orient themselves.

Design and trust in life science marketing

In B2B, trust rarely begins with persuasion. Instead, it begins with orientation.

Research from the Stanford Web Credibility Project shows that visual design plays a significant role in how people assess credibility. In large scale studies, users reported that visual design influenced their judgment of a site’s credibility before evaluating content quality.

In practical terms, buyers first assess whether they can understand what they are looking at without excessive effort. When design makes priorities clear, buyers feel guided rather than burdened. As a result, further evaluation feels worthwhile rather than risky.

When structure is weak, the opposite happens. Buyers must work harder to make sense of the content. They scan longer, jump between sections, or leave with the intention to return later. In many cases, that return never happens.

The R&D informatics market is very competitive with new players entering the market using modern and often aggressive marketing tactics. Despite being one of the most mature companies and the clear market leader IDBS’s branding didn’t reflect that reality. It was time to reignite the brand.

Why complexity increases the role of design

As offers become more complex, buyers must process more information to reach a decision. This increases cognitive load. Research on decision making shows that as information volume increases, decision time and hesitation increase unless structure reduces mental effort.

In practice, this leads more often to delay than rejection.

Common behaviours include bookmarking a page without returning or forwarding a link internally with little context. These behaviours signal uncertainty rather than lack of interest.

Design reduces this friction by making relationships between information visible. Grouping shows what belongs together. Sequencing clarifies what comes first. Clear page intent helps buyers decide where to focus attention without reading everything.

Design and the mid funnel decision tasks

During the consideration stage, buyers compare options, validate technical and organisational fit, and prepare to explain their recommendation internally.

Here, design supports these tasks through predictable structure. Equivalent information placed in consistent locations reduces the effort required to search. As a result, buyers can spend more time evaluating rather than navigating. Proof that is easy to locate and reference increases confidence, and pages that are easy to explain to others support internal alignment.

Why life science provides a clear test case

Life science marketing combines high technical complexity with strict regulatory requirements. Content must be accurate, precise, and defensible, while supporting long decision processes involving multiple stakeholders.

In addition, regulatory contexts increase volume. Technical documentation often runs into hundreds or thousands of pages. In this environment, structure becomes essential for orientation.

Design helps resolve the tension between correctness and clarity. It allows teams to maintain scientific rigor while still creating hierarchy and navigability, without changing claims.

Where life science marketing often loses effectiveness

Many life science organisations prioritise correctness above all else. Content passes through legal, regulatory, and scientific review. Over time, this process often flattens emphasis.

Headings lose specificity. Sections are added rather than prioritised. Claims are presented with equal weight.

The result is material that is accurate but difficult to navigate.

Typical symptoms include pages that open with long paragraphs, lack clear sectioning, and place supporting evidence after extensive explanation. As a consequence, buyers are forced to decide for themselves what matters most. This is also why we often see strong science fail to create confidence when structure is weak, something we explore further in our Communication Health Check.

This is rarely a lack of design capability. More often, it reflects internal caution. Decisions about emphasis are deferred, shifting the burden of prioritisation onto the buyer.

What trust consist of in life science contexts

Trust in life science is multi dimensional.

Buyers assess competence through clarity and consistency. They assess:

• compliance readiness through controlled language and predictable structure.
• scientific seriousness through data presentation and referencing.
• operational maturity through system consistency and ease of navigation.

Buyers rarely articulate these dimensions explicitly. However, their behaviour reflects them throughout the evaluation process.

Design contributes to each through structure rather than messaging.

Design and data presentation

Life science buyers look for evidence. How data is presented affects how rigor is perceived.

Charts that support comparison, readable tables, and easy to locate references reduce evaluation effort. Clear data presentation helps buyers verify conclusions rather than question them. Poorly structured data has the opposite effect.

In this context, understandability often determines whether evidence is trusted.

What strong design achieve in practice

In practice, strong design supports observable outcomes.

• Buyers find key information faster because page intent is clear.
• Proof is easier to locate because structure is predictable.
• Next steps are clearer because hierarchy reduces ambiguity.
• Inbound questions are more specific because buyers understand what they have seen.

Design does not change the substance of the message. Instead, it changes how accessible that substance feels.

A final perspective and a quick self check

In complex B2B environments, credibility is shaped by how information is presented as much as by what it contains. Buyers use design cues to decide whether further attention is justified.

A simple self check.

• Can a new visitor understand what you do within ten seconds.
• Is proof easy to find without extensive scrolling.
• Does the structure support internal sharing and discussion.

For life science organisations, strong design helps ensure that rigorous work is recognised as such. By reducing effort and increasing clarity, it supports trust where it matters most.